GV:NASDAQVisionary Holdings Inc. Analysis
Data as of 2026-06-21 - not real-time
$0.21
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Visionary Holdings (GV) is trading at $0.2075, just above its computed support of $0.20 and well below the 20‑day SMA of $0.268, indicating limited upside in the near term. The RSI of 39 suggests the stock is approaching oversold conditions, but the bearish MACD histogram and decreasing volume point to continued pressure. Volatility is extreme at over 150% annualized and the beta of ~0.81 signals modest correlation with the market, while a historic max drawdown of -94% underscores the price’s fragility.
Fundamentally, the company is in distress: revenue has collapsed by 62%, operating margins are deeply negative, and the balance sheet shows a debt‑to‑equity ratio of nearly 935, dwarfing its modest market cap of $1.16 M. Negative operating cash flow and zero dividend further limit any defensive appeal, making the current valuation of ~0.23 × book appear more a reflection of risk than a bargain.
Fundamentally, the company is in distress: revenue has collapsed by 62%, operating margins are deeply negative, and the balance sheet shows a debt‑to‑equity ratio of nearly 935, dwarfing its modest market cap of $1.16 M. Negative operating cash flow and zero dividend further limit any defensive appeal, making the current valuation of ~0.23 × book appear more a reflection of risk than a bargain.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and decreasing volume
- Price hovering near technical support
- Extreme volatility and recent max drawdown
Medium Term
1–3 yearsCautious
Model confidence: 8/10
Key Factors
- Sustained revenue decline and negative margins
- Debt‑to‑equity ratio exceeding 900
- Lack of positive cash flow generation
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- No clear turnaround roadmap
- Continued regulatory and operational uncertainties
- Persistent liquidity constraints
Key Metrics & Analysis
Financial Health
Revenue Growth-61.70%
ROE-137.27%
ROA-2.86%
Debt/Equity934.98
P/B Ratio0.2
Op. Cash Flow$-2968384
Free Cash Flow$-520235
Technical Analysis
TrendNeutral
RSI39.0
Support$0.20
Resistance$0.35
MA 20$0.27
MA 50$0.24
MA 200$1.02
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.81
Volatility157.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.